Zdrowie i gospodarka · 04/06/2013

FDA Requests Public Comments on Availability of Masked and De-identified Safety and Efficacy Data

The FDA is seeking public input on the potential release of anonymized and masked data from medical product applications, aiming to accelerate medical product development and maximize patient contributions to scientific knowledge.